Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Tuesday, June 29, 2021

Palliative care in hematopoietic stem-cell transplanted patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

xlomafota13 shared this article with you from Inoreader

Bull Cancer. 2021 Jun 24:S0007-4551(21)00125-9. doi: 10.1016/j.bulcan.2021.01.019. Online ahead of print.

ABSTRACT

Allogeneic hematopoietic cell transplantation (allo-HCT), the only curative therapy for numerous hematological malignancies, carries a significant risk of morbidity and mortality. The patients and families' expectations regarding the procedure, the prognosis uncertainties, as well as the existence of potential new therapeutic possibilities, lead to frequent use of intensive care. Even though the transplant physicians are highly skilled in acute care, their knowledge of palliative approach is limited, making the use of palliative care insufficient and often late. By promoting reflection on the proportionality of care and the patients' quality of life, palliative care may contribute to the allo-HCT patients management. Nevertheless, obstacles to this approach remain. The objective of this work is to propose recommendations t o promote the implementation of palliative care into transplant units.

PMID:34176584 | DOI:10.1016/j.bulcan.2021.01.019

View on the web

No comments:

Post a Comment